What is Dystonia Drugs Market?
The research done by the American Association of Neurological Surgeons, dystonia affects up to 250,000 people in the United States. Dis a type of neurological movement disorder that is characterized by irregular uncontrollable muscle contractions followed by involuntary twisting body parts and abnormal posture. Dystonia affects women more than men. The symptoms of dystonia are cramps in the foot, difficulty in speech, uncontrollable blinking, etc. Dystonia drugs can help the condition the common categories of drugs used in dystonia condition are, anticholinergic, benzodiazepine, dopamine drugs, and others. Dystonia is certifiably not a single disease yet a disorder – a bunch of indications that can't be attributed to a solitary reason yet share normal components. A few types of Dystonia may influence a particular body area, for example, the neck, face, jaw, eyes, appendages, or vocal cords.
The market study is being classified and major geographies with country level break-up.
Pfizer (United States), Novartis (Switzerland), Sanofi (France), Merck(United States), Aspen Pharma (South Africa), Merz Pharma GmbH & Co. KGaA (Germany), Ipsen (France), Revance Therapeutics, Inc. (United States), Boston Scientific Corporation(United States), Allergan, Inc.(Ireland) and Shineway (China) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Shijiazhuang Pharma Group (CSPC Pharmaceutical Group) (China) and Harbin Pharmaceutical Group (China).
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Dystonia Drugs market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Dystonia Drugs market by Type, Application and Region.
On the basis of geography, the market of Dystonia Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The growing awareness about dystonia therapy and technological advancement is driving the growth of the market
- Increase in the prevalence rate of dystonia disorders worldwide
- An increase in the rate of R&D initiatives is driving the dystonia therapeutics market
- The growing adoption of deep brain stimulation for the treatment of intractable movement disorders has led to the emergence of pallidal stimulation as the surgical therapy of choice for many patients with dystonia
- Increasing awareness about dystonia therapy is also expected to fuel the market growth during the forecast period
- Effective treatment is either unavailable or unaffordable
- Lack of knowledge about dystonia in some developing countries
In November 2019 Revance Therapeutics Inc a biotechnology company focused on innovative aesthetic and therapeutic offerings. Completes Enrollment in ASPEN-1 Phase 3 Pivotal Trial for Cervical Dystonia, has completed patient enrollment of the company’s pivotal ASPEN-1 Phase 3 clinical trial for its investigational drug candidate DaxibotulinumtoxinA for Injection (DAXI) for the treatment of isolated cervical dystonia (CD), a movement disorder affecting the neck. In total, 301 adult patients were enrolled at 60 sites across the U.S., Canada, and Europe.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Dystonia Drugs Manufacturer, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase